Breaking News Instant updates and real-time market news.

GILD

Gilead

$83.04

1.06 (1.29%)

04:52
10/11/17
10/11
04:52
10/11/17
04:52

Gilead reinstated with an Overweight at Barclays

Barclays analyst Geoff Meacham reinstated Gilead Sciences with an Overweight rating and $90 price target. The company will continue to attract investor attention as its expansion into oncology puts visibility into the resumption of growth, the analyst contends.

  • 06

    Nov

  • 12

    Feb

GILD Gilead
$83.04

1.06 (1.29%)

10/04/17
OPCO
10/04/17
INITIATION
OPCO
Perform
Gilead initiated with a Perform at Oppenheimer
Oppenheimer analyst Hartaj Singh started Gilead Sciences with a Perform rating, saying he believes the risk/reward is currently balanced. Near-term HCV consensus estimates are too conservative and HIV business growth is possible over the next 3-5 years, but near-term HCV competition and structural issues in the HCV market could still lead to some near-term downside, said Singh.
10/05/17
10/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Gilead (GILD) initiated with a Perform at Oppenheimer. 2. Mammoth Energy (TUSK) initiated with a Hold at Jefferies. 3. Heska (HSKA) initiated with a Buy at Canaccord. 4. Angie's List (ANGI) reinitiated with an Outperform at Oppenheimer. 5. CoStar Group (CSGP) reinstated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/17
MAXM
10/09/17
NO CHANGE
Target $56
MAXM
Buy
Juno price target raised to $56 on higher JCAR017 price assumptions at Maxim
Maxim analyst Jason McCarthy has increased his assumptions for pricing of Juno Therapeutics' (JUNO) JCAR017 to $450K from $300K in the U.S. and to $375K from $200K in the EU, leading him to also raise his price target on the stock to $56 from $34. He believes CAR-T remains "a three horse race," adding that while Novartis (NVS) and Gilead's (GILD) Kite are ahead, "Juno is coming up from behind." McCarthy maintains his Buy rating on Juno shares.
10/09/17
LEER
10/09/17
NO CHANGE
LEER
Leerink not worried about JAK safety, AbbVie '494 profile so far 'ok'
Leerink analyst Geoffrey Porges notes that the delayed approval of Incyte (INCY)/Eli Lilly (LLY) baricitinib and the reported thromboembolic events in AbbVie's (ABBV) ABT494/upadacitinib trials have called into question the safety of oral Janus kinase, or JAK, inhibitors. The analyst says that his detailed review of the safety literature suggests that these medicines offer an acceptable risk/benefit profile for serious inflammatory diseases and do not confer a significant increase in cardiovascular risk or venous thromboembolic events. Further, Porges continues to believe AbbVie's upadacitinib and Gilead's (GILD) filgotinib will be approved for serious inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease, and will capture the majority share of his peak risk-adjusted $12B estimated JAK market.

TODAY'S FREE FLY STORIES

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:32
02/21/18
02/21
17:32
02/21/18
17:32
Hot Stocks
Macquarie Infrastructure to reduce 2018 dividend to help fund asset repurposing »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ILG

ILG

$32.31

0.12 (0.37%)

17:30
02/21/18
02/21
17:30
02/21/18
17:30
Hot Stocks
ILG increases quarterly dividend »

ILG announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

TGB

Taseko Mines

$1.76

0.03 (1.73%)

17:28
02/21/18
02/21
17:28
02/21/18
17:28
Earnings
Taseko Mines reports Q4 adjusted EPS (C$0.01) vs. C$0.07 last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAND

Bandwidth

$24.09

0.18 (0.75%)

17:26
02/21/18
02/21
17:26
02/21/18
17:26
Earnings
Bandwidth sees FY18 adjusted EPS (11c)-0c, may not compare to consensus (34c) »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BAND

Bandwidth

$24.09

0.18 (0.75%)

17:25
02/21/18
02/21
17:25
02/21/18
17:25
Earnings
Bandwidth sees Q1 adjusted EPS 7c-10c, may not compare to consensus (6c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SM

SM Energy

$21.30

-0.54 (-2.47%)

17:25
02/21/18
02/21
17:25
02/21/18
17:25
Hot Stocks
SM Energy sees Q1 production 9.5-10.0 MMBoe »

Sees Q1 total capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BAND

Bandwidth

$24.09

0.18 (0.75%)

17:24
02/21/18
02/21
17:24
02/21/18
17:24
Earnings
Bandwidth reports Q4 adjusted EPS 9c, consensus 0c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SM

SM Energy

$21.30

-0.54 (-2.47%)

17:24
02/21/18
02/21
17:24
02/21/18
17:24
Hot Stocks
SM Energy sees 2018 production 42-46 MMBoe, 41% oil »

Sees 2018 total capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:24
02/21/18
02/21
17:24
02/21/18
17:24
Earnings
Pandora sees Q1 revenue $295M-$305M, consensus $322.87M »

Sees Q1 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

SM

SM Energy

$21.30

-0.54 (-2.47%)

17:23
02/21/18
02/21
17:23
02/21/18
17:23
Earnings
SM Energy reports Q4 adjusted EPS (8c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:22
02/21/18
02/21
17:22
02/21/18
17:22
Hot Stocks
Pandora expects FY18 top-line growth to come from subscription business »

Operating expenses will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

LNCE

Snyder's-Lance

$49.90

-0.1 (-0.20%)

17:22
02/21/18
02/21
17:22
02/21/18
17:22
Hot Stocks
Snyder's-Lance initiates recall for a limited amount of Glazed Walnuts product »

Emerald Nuts, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKE

Oneok

$56.10

-0.92 (-1.61%)

17:20
02/21/18
02/21
17:20
02/21/18
17:20
Hot Stocks
ONEOK to invest $2.3B for additional NGL, natural gas infrastructure »

ONEOK announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

GXP

Great Plains Energy

$29.45

-0.33 (-1.11%)

17:20
02/21/18
02/21
17:20
02/21/18
17:20
Earnings
Breaking Earnings news story on Great Plains Energy »

Great Plains Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:19
02/21/18
02/21
17:19
02/21/18
17:19
Hot Stocks
Breaking Hot Stocks news story on Macquarie Infrastructure »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:19
02/21/18
02/21
17:19
02/21/18
17:19
Earnings
Macquarie Infrastructure reports Q4 EPS $4.13, may not compare to consensus 51c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CAKE

Cheesecake Factory

$46.22

0.61 (1.34%)

17:18
02/21/18
02/21
17:18
02/21/18
17:18
Earnings
Cheesecake Factory sees FY18 EPS $2.64-$2.80, consensus $2.73 »

Sees FY18 SSS up 0%-1%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

UTX

United Technologies

$129.26

2.8 (2.21%)

17:17
02/21/18
02/21
17:17
02/21/18
17:17
Hot Stocks
United Technologies awarded $2.5B U.S. Defense Department contract »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IAG

IAMGold

$5.86

0.07 (1.21%)

17:17
02/21/18
02/21
17:17
02/21/18
17:17
Hot Stocks
IAMGold sees 2018 attributable gold production 850K-900K oz. »

Sees 2018 CapEx $365M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CAKE

Cheesecake Factory

$46.22

0.61 (1.34%)

17:16
02/21/18
02/21
17:16
02/21/18
17:16
Earnings
Cheesecake Factory sees Q1 EPS 66c-70c, consensus 68c »

Sees Q1 SSS up 0.5%-1.5%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:16
02/21/18
02/21
17:16
02/21/18
17:16
Hot Stocks
Breaking Hot Stocks news story on Pandora »

Pandora says Q4 mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

CLVS

Clovis

$54.93

1.22 (2.27%)

17:11
02/21/18
02/21
17:11
02/21/18
17:11
Hot Stocks
Clovis Oncology receives positive trend vote from CHMP for Rucaparib »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HBM

Hudbay Minerals

$8.15

0.1 (1.24%)

17:10
02/21/18
02/21
17:10
02/21/18
17:10
Hot Stocks
Hudbay Minerals sees FY18 production outlook unchanged »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

P

Pandora

$4.87

-0.46 (-8.63%)

17:10
02/21/18
02/21
17:10
02/21/18
17:10
Hot Stocks
Pandora sees significant opportunity to grow user count »

Comments from Q4 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

IAG

IAMGold

$5.86

0.07 (1.21%)

17:10
02/21/18
02/21
17:10
02/21/18
17:10
Earnings
IAMGold reports Q4 adjusted EPS (3c), consensus 1c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.